title: Affinity maturation of the BR96 anti-carcinoma antibody by codon-based mutagenesis.
abstract: We have increased up to 65-fold the avidity of BR96, a mAb recognizing Lewis Y (Le(y))-related Ags expressed on the surface of many human carcinomas. Libraries of mutations in the complementarity-determining regions (CDRs) of BR96 were constructed in an M13 phage Fab expression vector by codon-based mutagenesis, a method that efficiently introduces large numbers and potentially all combinations of amino acid substitutions. Two mutants that improved the affinity of BR96 to tumor Ag were identified by screening the libraries on carcinoma cell lines. One mutant, M1, at position 97 (Asp to Ala) in CDR3 of the heavy chain, resulted in an 8- to 10-fold improvement in Ag binding, as assessed by ELISA. A second mutant, M2, at position 53 (Gly to Asp) in CDR2 of VH increased binding three- to fivefold. When these mutations were combined, the resulting Fab M3 was improved approximately 30-fold. An additional library was constructed in CDR1 of M1. M4, a mutation with three amino acid substitutions in CDR1, was isolated by screening the library with an enzyme conjugate of synthetic Le(y) tetrasaccharide (sLe(y)). This mutant improved BR96 Fab affinity to sLe(y) an estimated 15- to 20-fold by ELISA, and 14-fold as measured by surface plasmon resonance. The M4 IgG had 65-fold improved avidity to sLe(y) relative to the BR96 IgG. The mutants will be useful for comparison of the efficacy of Abs with different affinities for delivery of cytotoxic agents to tumor cells.
authors.affiliation: Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, WA 98121, USA.
authors.forename: D E
authors.initials: DE
authors.lastname: Yelton
authors.forename: M J
authors.initials: MJ
authors.lastname: Rosok
authors.forename: G
authors.initials: G
authors.lastname: Cruz
authors.forename: W L
authors.initials: WL
authors.lastname: Cosand
authors.forename: J
authors.initials: J
authors.lastname: Bajorath
authors.forename: I
authors.initials: I
authors.lastname: Hellström
authors.forename: K E
authors.initials: KE
authors.lastname: Hellström
authors.forename: W D
authors.initials: WD
authors.lastname: Huse
authors.forename: S M
authors.initials: SM
authors.lastname: Glaser
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000235:genetics / Q000378:metabolism*; D000912:Antibodies, Neoplasm / Q000235:genetics / Q000378:metabolism*; D000915:Antibody Affinity; D015295:Antigens, Tumor-Associated, Carbohydrate / Q000276:immunology*; D001483:Base Sequence; D003062:Codon; D015723:Gene Library; D005803:Genes, Immunoglobulin; D005822:Genetic Vectors; D006801:Humans; D051379:Mice; D008969:Molecular Sequence Data; D016296:Mutagenesis; D013329:Structure-Activity Relationship
chemical_list: D000911:Antibodies, Monoclonal; D000912:Antibodies, Neoplasm; D015295:Antigens, Tumor-Associated, Carbohydrate; D003062:Codon